Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
Figure 4
Late effects in normal tissues subjective, objective, management and analytic scales (LENT/SOMA) data. Change in maximum scores per symptom area between nonsignificant scores (score 0,1) and significant scores (≥2) at baseline, 2-year and 7-year followup (Figure 4(b). Bowel function, *baseline to 7 years ).
